Delivery Order SPE2DB20D2014-SPE2DB25FC76E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract valued at $23,977.17. The delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $11,743.92. This firm fixed price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $60,027.48. This non-set-aside delivery order is scheduled for ultimate completion by August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $94,228.99 and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, valued at $106,293.56, is scheduled for completion by August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order valued at $3,489.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 13, 2025, with a completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply support to federal healthcare systems. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract type. The order, valued at $4,520.58, is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designations, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units, with a ceiling value of $8,606.87. This competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC76EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets in a 90-count quantity, with a contract ceiling value of $8,050.08 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded procurement and is scheduled for completion by August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 8/15/25 |